AAAAAA
Results:
1-11
|
Results: 11
Authors:
FORSBLOM CM
GROOP PH
EKSTRAND A
TOTTERMAN KJ
SANE T
SALORANTA C
GROOP L
Citation: Cm. Forsblom et al., PREDICTORS OF PROGRESSION FROM NORMOALBUMINURIA TO MICROALBUMINURIA IN NIDDM, Diabetes care, 21(11), 1998, pp. 1932-1938
Authors:
FORSBLOM CM
SANE T
GROOP PH
TOTTERMAN KJ
KALLIO M
SALORANTA C
LAASONEN L
SUMMANEN P
LEPANTALO M
LAATIKAINEN L
MATIKAINEN E
TEPPO AM
KOSKIMIES S
GROOP L
Citation: Cm. Forsblom et al., RISK-FACTORS FOR MORTALITY IN TYPE-II (NON-INSULIN-DEPENDENT) DIABETES - EVIDENCE OF A ROLE FOR NEUROPATHY AND A PROTECTIVE EFFECT OF HLA-DR4, Diabetologia, 41(11), 1998, pp. 1253-1262
Authors:
SALORANTA C
FORSBLOM C
HYRKKO A
LEHTOVIRTA M
GROOP L
Citation: C. Saloranta et al., ABDOMINAL OBESITY IS ASSOCIATED WITH IMPAIRED NEFA SUPPRESSION IN NORMAL GLUCOSE TOLERANT RELATIVES TO NIDDM SUBJECTS, Diabetologia, 41, 1998, pp. 272-272
Authors:
FORSBLOM C
SALORANTA C
KARANKO S
GROOP L
Citation: C. Forsblom et al., INCREASED ALBUMIN EXCRETION RATE IN NONDIABETIC OFFSPRING OF NIDDM PATIENTS WITH DIABETIC NEPHROPATHY, Diabetologia, 40, 1997, pp. 65-65
Authors:
SALORANTA C
TAHVANAINEN K
LIPSANENNYMAN M
KUUSELA T
AKERBLOM H
Citation: C. Saloranta et al., DECREASED PARASYMPATHETIC TONE IN YOUNG IDDM PATIENTS, Diabetologia, 40, 1997, pp. 2215-2215
Authors:
SALORANTA C
GROOP L
Citation: C. Saloranta et L. Groop, INTERACTIONS BETWEEN GLUCOSE AND FFA METABOLISM IN MAN, Diabetes/metabolism reviews, 12(1), 1996, pp. 15-36
Authors:
EKSTRAND A
SCHALINJANTTI C
LOFMAN M
PARKKONEN M
WIDEN E
FRANSSILAKALLUNKI A
SALORANTA C
KOIVISTO V
GROOP L
Citation: A. Ekstrand et al., THE EFFECT OF (STEROID) IMMUNOSUPPRESSION ON SKELETAL-MUSCLE GLYCOGEN-METABOLISM IN PATIENTS AFTER KIDNEY-TRANSPLANTATION, Transplantation, 61(6), 1996, pp. 889-893
Authors:
SALORANTA C
GROOP L
EKSTRAND A
FRANSSILAKALLUNKI A
TASKINEN MR
Citation: C. Saloranta et al., THE EFFECT OF AN ANTILIPOLYTIC AGENT (ACIPIMOX) ON THE INSULIN-RESISTANCE OF LIPID AND GLUCOSE-METABOLISM IN HYPERTRIGLYCERIDEMIC PATIENTS, Acta diabetologica, 31(1), 1994, pp. 6-13
Authors:
SALORANTA C
GROOP L
EKSTRAND A
FRANSSILAKALLUNKI A
ERIKSSON J
TASKINEN MR
Citation: C. Saloranta et al., DIFFERENT ACUTE AND CHRONIC EFFECTS OF ACIPIMOX TREATMENT ON GLUCOSE AND LIPID-METABOLISM IN PATIENTS WITH TYPE-2 DIABETES, Diabetic medicine, 10(10), 1993, pp. 950-957
Authors:
SALORANTA C
TASKINEN MR
WIDEN E
HARKONEN M
MELANDER A
GROOP L
Citation: C. Saloranta et al., METABOLIC CONSEQUENCES OF SUSTAINED SUPPRESSION OF FREE FATTY-ACIDS BY ACIPIMOX IN PATIENTS WITH NIDDM, Diabetes, 42(11), 1993, pp. 1559-1566
Authors:
SALORANTA C
KOIVISTO V
WIDEN E
FALHOLT K
DEFRONZO RA
HARKONEN M
GROOP L
Citation: C. Saloranta et al., CONTRIBUTION OF MUSCLE AND LIVER TO GLUCOSE-FATTY ACID CYCLE IN HUMANS, The American journal of physiology, 264(4), 1993, pp. 599-605
Risultati:
1-11
|